Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation

Gene

Volumn 446, Issue 1, 2009, Pages 18-27

  Wang, Zhipeng ^a   Nishimura, Yuhei ^a,b   Shimada, Yasuhito ^a,b   Umemoto, Noriko ^a   Hirano, Minoru ^a   Zang, Liqing ^a   Oka, Takehiko ^a   Sakamoto, Chikara ^a   Kuroyanagi, Junya ^a   Tanaka, Toshio ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

beta Adrenergic receptors; F1F0 ATPase complex; Pigmentation; Zebrafish

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADRB1 PROTEIN; ADRB2A PROTEIN; ADRB2B PROTEIN; ADRB3A PROTEIN; ADRB3B PROTEIN; ADRB5A1 PROTEIN; ADRB5B PROTEIN; BETA ADRENERGIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART; LIVER; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; PIGMENTATION; PRIORITY JOURNAL; SKIN; TISSUE DISTRIBUTION; ZEBRA FISH;

ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHENOTYPE; PHYLOGENY; PIGMENTATION; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SPECIES SPECIFICITY; TISSUE DISTRIBUTION; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO;

EID: 68149165756     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.06.005     Document Type: Article

References (75)

1. Amores A., et al. Zebrafish hox clusters and vertebrate genome evolution. Science 282 (1998) 1711-1714
2. +-ATP synthase as a potential molecular target for anti-obesity drugs. FEBS Lett. 581 (2007) 3405-3409
3. Bachman E., et al. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297 (2002) 843-845
4. Barreau C., Paillard L., and Osborne H. AU-rich elements and associated factors: are there unifying principles?. Nucleic Acids Res. 33 (2005) 7138-7150
5. Braasch I., Schartl M., and Volff J. Evolution of pigment synthesis pathways by gene and genome duplication in fish. BMC Evol. Biol. 7 (2007) 74
6. Burge C., and Karlin S. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268 (1997) 78-94
7. Buscà R., and Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13 (2000) 60-69
8. Chen X., Harden T., and Nicholas R. Molecular cloning and characterization of a novel beta-adrenergic receptor. J. Biol. Chem. 269 (1994) 24810-24819
9. Chen K., Minwalla L., Ni L., and Orlow S. Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes. Pigment Cell Res. 17 (2004) 36-42
10. Choi T., et al. Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res. 20 (2007) 120-127
11. Chruscinski A., Rohrer D., Schauble E., Desai K., Bernstein D., and Kobilka B. Targeted disruption of the beta2 adrenergic receptor gene. J. Biol. Chem. 274 (1999) 16694-16700
12. Collins S., Altschmied J., Herbsman O., Caron M., Mellon P., and Lefkowitz R. A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP. J. Biol. Chem. 265 (1990) 19330-19335
13. del Marmol V., and Beermann F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381 (1996) 165-168
14. Dugan S., Chen X., Nickerson J., Montpetit C., and Moon T. Regulation of the black bullhead hepatic beta-adrenoceptors. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 149 (2008) 265-274
15. Dulloo A. Biomedicine. A sympathetic defense against obesity. Science 297 (2002) 780-781
16. Eisen J., and Smith J. Controlling morpholino experiments: don't stop making antisense. Development 135 (2008) 1735-1743
17. Erraji-Benchekroun L., et al. Overexpression of beta2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E715-E722
18. Fujii R. The regulation of motile activity in fish chromatophores. Pigment Cell Res. 13 (2000) 300-319
19. Gillbro J., Marles L., Hibberts N., and Schallreuter K. Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentation in human epidermal melanocytes. J. Invest. Dermatol. 123 (2004) 346-353
20. Grando S., Pittelkow M., and Schallreuter K. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J. Invest. Dermatol. 126 (2006) 1948-1965
21. Guo N., and Li B. Cellular and subcellular distributions of beta1- and beta2-adrenoceptors in the CA1 and CA3 regions of the rat hippocampus. Neuroscience 146 (2007) 298-305
22. Gwathmey J., et al. Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. Am. J. Physiol. 276 (1999) H1678-H1690
23. Györffy B., and Lage H. A Web-based data warehouse on gene expression in human malignant melanoma. J. Invest. Dermatol. 127 (2007) 394-399
24. Hultman K., Bahary N., Zon L., and Johnson S. Gene duplication of the zebrafish kit ligand and partitioning of melanocyte development functions to kit ligand a. PLoS Genet. 3 (2007) e17
25. Izquierdo J. Control of the ATP synthase beta subunit expression by RNA-binding proteins TIA-1, TIAR, and HuR. Biochem. Biophys. Res. Commun. 348 (2006) 703-711
26. Jimbow K., et al. Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study. Pigment Cell Res. 10 (1997) 206-213
27. Jung D., et al. Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol. Biosyst. 1 (2005) 85-92
28. Kawarai M., and Koss M. Sympathetic vasodilation in the rat anterior choroid mediated by beta(1)-adrenoceptors. Eur. J. Pharmacol. 386 (1999) 227-233
29. Kim D., Park S., and Park K. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int. J. Biochem. Cell Biol. 36 (2004) 1482-1491
30. Kimmel C., Ballard W., Kimmel S., Ullmann B., and Schilling T. Stages of embryonic development of the zebrafish. Dev. Dyn. 203 (1995) 253-310
31. Klöss S., Srivastava R., and Mülsch A. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Mol. Pharmacol. 65 (2004) 1440-1451
32. Koch P., et al. Regulation of dopa decarboxylase expression during colour pattern formation in wild-type and melanic tiger swallowtail butterflies. Development 125 (1998) 2303-2313
33. Krasagakis K., Garbe C., Eberle J., and Orfanos C. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch. Dermatol. Res. 287 (1995) 259-265
34. Lamason R., et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 310 (2005) 1782-1786
35. Lieschke G., and Currie P. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8 (2007) 353-367
36. Lister J., Robertson C., Lepage T., Johnson S., and Raible D. nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development 126 (1999) 3757-3767
37. Lynch M., and Conery J. The evolutionary fate and consequences of duplicate genes. Science 290 (2000) 1151-1155
38. Machida C., et al. Molecular cloning and expression of the rat beta 1-adrenergic receptor gene. J. Biol. Chem. 265 (1990) 12960-12965
39. Madsen E., Morcos P., Mendelsohn B., and Gitlin J. In vivo correction of a Menkes disease model using antisense oligonucleotides. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3909-3914
40. Marshall O. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20 (2004) 2471-2472
41. Martínez-Esparza M., Jiménez-Cervantes C., Solano F., Lozano J., and García-Borrón J. Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells. Eur. J. Biochem. 255 (1998) 139-146
42. Martínez-Esparza M., Solano F., and García-Borrón J. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell Mol. Biol. (Noisy-le-grand) 45 (1999) 991-1000
43. Meyer A., and Van de Peer Y. From 2R to 3R: evidence for a fish-specific genome duplication (FSGD). Bioessays 27 (2005) 937-945
44. Mishima Y. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors. Pigment Cell Res. 7 (1994) 376-387
45. Müller T., and Vingron M. Modeling amino acid replacement. J. Comput. Biol. 7 (2000) 761-776
46. Nakamura A., Imaizumi A., Yanagawa Y., Niimi R., and Kohsaka T. Suppression of tumor necrosis factor-alpha by beta2-adrenoceptor activation: role of mitogen-activated protein kinases in renal mesangial cells. Inflamm. Res. 52 (2003) 26-31
47. Nasevicius A., and Ekker S. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26 (2000) 216-220
48. Ni-Komatsu L., and Orlow S. Identification of novel pigmentation modulators by chemical genetic screening. J. Invest. Dermatol. 127 (2007) 1585-1592
49. Nickerson J., Dugan S., Drouin G., and Moon T.A. putative beta2-adrenoceptor from the rainbow trout (Oncorhynuchus mykiss). Molecular characterization and pharmacology. Eur. J. Biochem. 268 (2001) 6465-6472
50. + exchanger in trout erythrocytes is controlled by a novel beta3-AR subtype. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R526-R535
51. Orenberg E., Pfendt E., and Wilkinson D. Characterization of alpha- and beta-adrenergic agonist stimulation of adenylate cyclase activity in human epidermal keratinocytes in vitro. J. Invest. Dermatol. 80 (1983) 503-507
52. Page R. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12 (1996) 357-358
53. Park H., Perez J., Laursen R., Hara M., and Gilchrest B. Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J. Biol. Chem. 274 (1999) 16470-16478
54. Park H., Wu H., Killoran C., and Gilchrest B. The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J. Cell. Sci. 117 (2004) 3659-3668
55. Pickart M., Sivasubbu S., Nielsen A., Shriram S., King R., and Ekker S. Functional genomics tools for the analysis of zebrafish pigment. Pigment Cell Res. 17 (2004) 461-470
56. Postlethwait J., et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 10 (2000) 1890-1902
57. Rockman H., Koch W., and Lefkowitz R. Seven-transmembrane-spanning receptors and heart function. Nature 415 (2002) 206-212
58. Rohrer D., et al. Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7375-7380
59. Rohrer D., Chruscinski A., Schauble E., Bernstein D., and Kobilka B. Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J. Biol. Chem. 274 (1999) 16701-16708
60. Salem M., Levesque H., Moon T., Rexroad C., and Yao J. Anabolic effects of feeding beta2-adrenergic agonists on rainbow trout muscle proteases and proteins. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 144 (2006) 145-154
61. Saraste M. Oxidative phosphorylation at the fin de siècle. Science 283 (1999) 1488-1493
62. Schallreuter K., Kothari S., Chavan B., and Spencer J. Regulation of melanogenesis-controversies and new concepts. Exp. Dermatol. 17 (2008) 395-404
63. Schmidt H., Strimmer K., Vingron M., and von Haeseler A. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18 (2002) 502-504
64. Schwerte T., Prem C., Mairösl A., and Pelster B. Development of the sympatho-vagal balance in the cardiovascular system in zebrafish (Danio rerio) characterized by power spectrum and classical signal analysis. J. Exp. Biol. 209 (2006) 1093-1100
65. Shin J., and Fishman M. From zebrafish to human: modular medical models. Annu. Rev. Genomics Hum. Genet. 3 (2002) 311-340
66. Sivamani R., Lam S., and Isseroff R. Beta adrenergic receptors in keratinocytes. Dermatol. Clin. 25 (2007) 643-653 x
67. Smith B., Fang H., Pan Y., Walker P., Famili A., and Sikorska M. Evolution of motif variants and positional bias of the cyclic-AMP response element. BMC Evol. Biol. 7 Suppl. 1 (2007) S15
68. Steinkraus V., Mak J., Pichlmeier U., Mensing H., Ring J., and Barnes P. Autoradiographic mapping of beta-adrenoceptors in human skin. Arch. Dermatol. Res. 288 (1996) 549-553
69. Tanaka T., et al. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models. J. Pharmacol. Sci. 107 (2008) 8-14
70. Taylor M. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics J. 7 (2007) 29-37
71. Van Heeswijk J., Vianen G., and van den Thillart G. The adrenergic control of hepatic glucose and FFA metabolism in rainbow trout (Oncorhynchus mykiss): increased sensitivity to adrenergic stimulation with fasting. Gen. Comp. Endocrinol. 145 (2006) 51-61
72. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio). Fourth ed (2000), University of Oregon Press, Eugene, USA
73. Woods I., et al. A comparative map of the zebrafish genome. Genome Res. 10 (2000) 1903-1914
74. Xiang Y., and Kobilka B. Myocyte adrenoceptor signaling pathways. Science 300 (2003) 1530-1532
75. Yang G., Zhang G., Pittelkow M., Ramoni M., and Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J. Invest. Dermatol. 126 (2006) 2490-2506